Integrated Diagnostics Holdings plc (IDGXF)

Market Cap	348.80M +70.9%
Revenue (ttm)	164.68M +37.3%
Net Income	26.46M +17.1%
EPS	0.05 +19.6%
Shares Out	n/a
PE Ratio	13.18
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	937
Average Volume	2,246
Open	0.59465
Previous Close	n/a
Day's Range	0.59465 - 0.59465
52-Week Range	0.3200 - 0.6983
Beta	0.39
RSI	55.91
Earnings Date	Sep 2, 2026

About IDGXF

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalog...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 7,137
• Stock Exchange: OTCMKTS
• Ticker Symbol: IDGXF

Financial Performance

In 2025, IDGXF's revenue was 7.86 billion, an increase of 37.34% compared to the previous year's 5.72 billion. Earnings were 1.26 billion, an increase of 17.15%.

Financial numbers in EGP